Latest News about AZN
Recent news which mentions AZN
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week
December 19, 2021
From Benzinga
Is This New Data on Valneva's Less-Effective Booster Concerning?
December 18, 2021
From Motley Fool
A COVID-19 recovery offers low protection against omicron variant but boosters are effective, London study finds
December 17, 2021
From MarketWatch
This New Study Could Give Moderna a Big Advantage in 2022
December 17, 2021
From Motley Fool
Johnson & Johnson's, Sputnik, Sinopharm COVID-19 Vaccines Show Weakness Against Omicron Variant: Study
December 17, 2021
From Benzinga
AstraZeneca's COVID-19 Antibody Effective Against Omicron Variant
December 16, 2021
From Benzinga
Drug makers move forward with new COVID-19 booster candidates amid omicron’s spread and mass booster campaigns
December 15, 2021
From MarketWatch
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
December 15, 2021
From Benzinga
The Use of High Pressure is Transforming the Nutraceuticals (CBD), Food & Beverage, Healthcare, and other Billion-Dollar Markets
December 14, 2021
From Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
From Benzinga
Samsung Biologics, AstraZeneca Expand Collaboration To Include COVID-19, Cancer Therapy
December 14, 2021
From Benzinga
UK Reports First Omicron Death, PM Johnson Encourages Boosters
December 13, 2021
From Benzinga
2 Top Biotech Stocks To Buy Right Now
December 13, 2021
From Motley Fool
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
From Benzinga
How Quickly Could Vaccines Targeting the Omicron Variant Be Available?
December 11, 2021
From Motley Fool
From Benzinga
Omicron cases have been ‘mild,’ says CDC director, though majority so far are in the vaccinated
December 09, 2021
From MarketWatch
Innate Pharma Says Chemo-Free Monalizumab Triplet Therapy Shows Preliminary Anti-Cancer Activity
December 09, 2021
From Benzinga
AstraZeneca's COVID-19 Therapy Wins FDA Approval As First Antibody To Prevent Infection In Immunocompromised
December 09, 2021
From Benzinga
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
December 09, 2021
From Benzinga
Why Novavax Stock Is Soaring Today
December 07, 2021
From Motley Fool
Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response
December 07, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
From Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
Ionis, AstraZeneca Ink Licensing Pact For Eplontersen In Protein Misfolding Disorder
December 07, 2021
From Benzinga
From Benzinga
Johnson & Johnson Booster COVID-19 Shot Shows Encouraging Action After Pfizer/BioNTech Jab
December 06, 2021
From Benzinga
Here's Why AstraZeneca Stock Could Help Make You Rich
December 04, 2021
Tickers
AZN
From Motley Fool
From Motley Fool
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.